Medical devices

Global Glaucoma Surgery Devices Market to 2030 - Analysis and Forecast Model - ResearchAndMarkets.com

Friday, April 16, 2021 - 5:21pm

b'The "Glaucoma Surgery Devices (Ophthalmic Devices) - Global Market Analysis and Forecast Model (COVID-19 Market Impact)" report has been added to ResearchAndMarkets.com\'s offering.\nThis report was built to visualize quantitative market trends within Ophthalmic Devices therapeutic area.\nThe model discusses in detail the impact of COVID-19 on Glaucoma Surgery Devices market for the year 2020 and beyond.

Key Points: 
  • b'The "Glaucoma Surgery Devices (Ophthalmic Devices) - Global Market Analysis and Forecast Model (COVID-19 Market Impact)" report has been added to ResearchAndMarkets.com\'s offering.\nThis report was built to visualize quantitative market trends within Ophthalmic Devices therapeutic area.\nThe model discusses in detail the impact of COVID-19 on Glaucoma Surgery Devices market for the year 2020 and beyond.
  • To increase the data transparency, the interactive excel deliverable covers installed base, new sales volumes, product usage, average selling prices, market size and company share/rank analysis (wherever available).
  • Moreover, analyst comments with qualitative insight offer context for quantitative data.\nKey Inclusions of the market model are:\nInsightful review of the key industry trends.\nAnnualized total Glaucoma Surgery Devices market revenue by segment and market outlooks from 2015-2030.\nGranular data on total procedures, units, average selling prices and market values by segment.\nQualitative market specific information is available with global trends further broken down into regional trends.
  • In addition, the publisher analysts provide unique country specific insights on the market.\nSWOT analysis for Glaucoma Surgery Devices market.\nCompetitive dynamics insights and trends provided for Venous Stents market.\nDrive the understanding of the market by getting the veritable big picture including an overview of the healthcare system.

Global Drug-Eluting Balloon Industry Report 2021 with Focus on the Chinese Market - ResearchAndMarkets.com

Friday, April 16, 2021 - 3:51pm

b'The "Global and Chinese Drug-Eluting Balloon Industry, 2021 Market Research Report" has been added to ResearchAndMarkets.com\'s offering.\n\'Global and Chinese Drug-Eluting Balloon Industry, 2021 Market Research Report\' is a professional and in-depth study on the current state of the global Drug-Eluting Balloon industry with a focus on the Chinese market.

Key Points: 
  • b'The "Global and Chinese Drug-Eluting Balloon Industry, 2021 Market Research Report" has been added to ResearchAndMarkets.com\'s offering.\n\'Global and Chinese Drug-Eluting Balloon Industry, 2021 Market Research Report\' is a professional and in-depth study on the current state of the global Drug-Eluting Balloon industry with a focus on the Chinese market.
  • In this part, the report presents the company profile, product specifications, capacity, production value, and 2016-2021 market shares for each company.\nThrough statistical analysis, the report depicts the global and Chinese total market of Drug-Eluting Balloon industry including capacity, production, production value, cost/profit, supply/demand and Chinese import/export.
  • The total market is further divided by company, by country, and by application/type for the competitive landscape analysis.\nThe report then estimates 2021-2026 market development trends of the Drug-Eluting Balloon industry.
  • In the end, the report makes some important proposals for a new project of the Drug-Eluting Balloon Industry before evaluating its feasibility.\nOverall, the report provides an in-depth insight of the 2021 global and Chinese Drug-Eluting Balloon industry covering all important parameters.\n'

Global Bronchodilators Market Trajectory & Analytics Report 2021: Market to Reach a Revised Size $41.5 Billion by 2027 - Asthma Segment to Account for $17.6 Billion - ResearchAndMarkets.com

Friday, April 16, 2021 - 2:28pm

China, the world`s second largest economy, is forecast to reach a projected market size of US$8.9 Billion by the year 2027 trailing a CAGR of 8.2% over the analysis period 2020 to 2027.

Key Points: 
  • China, the world`s second largest economy, is forecast to reach a projected market size of US$8.9 Billion by the year 2027 trailing a CAGR of 8.2% over the analysis period 2020 to 2027.
  • Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 2.8% and 4% respectively over the 2020-2027 period.
  • Within Europe, Germany is forecast to grow at approximately 3.6% CAGR.\nIn the global Other Indications segment, USA, Canada, Japan, China and Europe will drive the 3.9% CAGR estimated for this segment.
  • Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$5.6 Billion by the year 2027, while Latin America will expand at a 4.4% CAGR through the analysis period.\n'

Global Inhaled Nitric Oxide Market (2020 to 2026) - by Application and Region - ResearchAndMarkets.com

Friday, April 16, 2021 - 1:01pm

The gas is quickly collected by oxyhemoglobin in red blood cells and the vasodilating effects caused by inhaled nitric oxide are restricted to oxygenated areas of the lungs.

Key Points: 
  • The gas is quickly collected by oxyhemoglobin in red blood cells and the vasodilating effects caused by inhaled nitric oxide are restricted to oxygenated areas of the lungs.
  • Hence, the inhaled nitric oxide is utilized to cure various cardiopulmonary conditions, like pulmonary hypertension in adults and children.
  • Apart from this, the huge cost involved in the treatment & the stringent government policies on different applications of the gas are restricting the growth of Inhaled Nitric Oxide market.
  • Inhaled Nitric Oxide is useful in safeguarding the frontline healthcare workers from this pandemic.\n'

Global Portable Compressor Nebulizer Market (2020 to 2025) - by Type, Application, Distribution Channel and Geography - ResearchAndMarkets.com

Friday, April 16, 2021 - 12:55pm

In Nov 2018, Koninklijke Philips launched InnoSpire Go portable nebulizer in the U.S.

Key Points: 
  • In Nov 2018, Koninklijke Philips launched InnoSpire Go portable nebulizer in the U.S.
  • Moreover, ARIKAYCE is used for the treatment of mycobacterium avium complex lung disease in adult patients.\nThe report offers a comprehensive evaluation of the Global Portable Compressor Nebulizer Market .
  • The report includes in-depth qualitative analysis, verifiable data from authentic sources, and projections about market size.
  • The projections are calculated using proven research methodologies.\nThe report has been compiled through extensive primary and secondary research.

Insights on the Smart Inhalers Global Market to 2025 - Competitive Analysis and the Impact of COVID-19 - ResearchAndMarkets.com

Friday, April 16, 2021 - 12:45pm

AptarGroup, Inc has partnered with Sonmol for developing connected drug delivery devices, digital therapies, and services platform for respiratory and other diseases - 21st April 2020\n2.

Key Points: 
  • AptarGroup, Inc has partnered with Sonmol for developing connected drug delivery devices, digital therapies, and services platform for respiratory and other diseases - 21st April 2020\n2.
  • - 11th March 2020\nThe report offers a comprehensive evaluation of the Global Smart Inhalers Market.
  • The report includes in-depth qualitative analysis, verifiable data from authentic sources, and projections about market size.
  • The impact of Covid-19 on the market is also featured in the report.\nThe report also contains the competitive analysis using IGR Positioning Quadrants, the analyst's proprietary competitive positioning tool.\nA complete analysis of the market, including parent industry\n"

Worldwide Optical Preclinical Imaging Industry to 2025 - Increasing Use of Preclinical Imaging in Various Sectors is Driving Growth - ResearchAndMarkets.com

Friday, April 16, 2021 - 12:41pm

In 2019, Kawasaki Medical University, the research center for state of the art medical science and services in Yokahama, acquired an ultra-high resolution E class system for preclinical imaging and installed the first system in Japan.\nThe report offers a comprehensive evaluation of the Global Optical Preclinical Imaging Market.

Key Points: 
  • In 2019, Kawasaki Medical University, the research center for state of the art medical science and services in Yokahama, acquired an ultra-high resolution E class system for preclinical imaging and installed the first system in Japan.\nThe report offers a comprehensive evaluation of the Global Optical Preclinical Imaging Market.
  • The report includes in-depth qualitative analysis, verifiable data from authentic sources, and projections about market size.
  • The projections are calculated using proven research methodologies.\nThe report has been compiled through extensive primary and secondary research.
  • The primary research is done through interviews, surveys, and observation of renowned personnel in the industry.\nThe report includes in-depth market analysis using Porter's 5 force model and the Ansoff Matrix.

In-Vitro Diagnostics Market Forecast to 2027 - Global COVID-19 Impact and Analysis by Product and Services, Technology, Application, and End User - ResearchAndMarkets.com

Friday, April 16, 2021 - 12:04pm

b'The "In-Vitro Diagnostics Market Forecast to 2027 - COVID-19 Impact and Global Analysis by Product and Services, Technology, Application, and End User, and Geography" report has been added to ResearchAndMarkets.com\'s offering.\nIn-Vitro Diagnostics Market is expected to reach US$ 90,656.80 million by 2027 from US$ 63,746.63 million in 2019.

Key Points: 
  • b'The "In-Vitro Diagnostics Market Forecast to 2027 - COVID-19 Impact and Global Analysis by Product and Services, Technology, Application, and End User, and Geography" report has been added to ResearchAndMarkets.com\'s offering.\nIn-Vitro Diagnostics Market is expected to reach US$ 90,656.80 million by 2027 from US$ 63,746.63 million in 2019.
  • The market is estimated to grow at a CAGR of 4.5% from 2020 to 2027.\nIn terms of product & services, the in-vitro diagnostics market is segmented into instruments, reagents & kits, and software & services.\nIn 2019, the reagents & kits segment held a largest market share of the in-vitro diagnostics market.
  • This segment is also expected to dominate the market during the forecast period owing to increasing number of diagnostics tests and rising prevalence of chronic conditions.\nMoreover, the instruments segment is anticipated to witness considerable growth rate during the forecast period.
  • It is likely to help in determining the best treatment strategy for each patient.\nThe image analysis algorithms uses artificial intelligence to support pathologists in making faster, more accurate patient diagnoses in breast cancer.\n'

Labcorp to Webcast Its Annual Meeting of Shareholders

Friday, April 16, 2021 - 12:01pm

b'Labcorp (NYSE: LH), a leading global life sciences company, today announced that its Annual Meeting of Shareholders will be webcast live beginning May 12, at 9:00 a.m.

Key Points: 
  • b'Labcorp (NYSE: LH), a leading global life sciences company, today announced that its Annual Meeting of Shareholders will be webcast live beginning May 12, at 9:00 a.m.
  • Through our unparalleled diagnostics and drug development capabilities, we provide insights and accelerate innovations to improve health and improve lives.
  • Each of the forward-looking statements is subject to change based on various important factors, many of which are beyond the company\xe2\x80\x99s control.
  • As a result, readers are cautioned not to place undue reliance on any of our forward-looking statements.

Molecular Diagnostics Market by Product & Service, Application, Technology and End-user - Global Forecast to 2026 - ResearchAndMarkets.com

Friday, April 16, 2021 - 11:58am

On the other hand, an unfavorable reimbursement scenario and the high cost of instruments is expected to limit market growth to a certain extent in the coming years.\nThe reagents & kits accounted for the highest growth rate in the molecular diagnostics market, by product & service, during the forecast period\nThe molecular diagnostics market is segmented into reagents & kits, instruments and other products.

Key Points: 
  • On the other hand, an unfavorable reimbursement scenario and the high cost of instruments is expected to limit market growth to a certain extent in the coming years.\nThe reagents & kits accounted for the highest growth rate in the molecular diagnostics market, by product & service, during the forecast period\nThe molecular diagnostics market is segmented into reagents & kits, instruments and other products.
  • The reagents & kits segment accounted for the highest growth rate in the molecular diagnostics market in 2020.
  • The requirement reagents & kits in large numbers compared to instruments is the main factor contributing to this segment\'s high growth rate.
  • This segment\'s market growth can also be attributed to repeat purchases of reagents & kits compared to instruments.\nBased on the application, the molecular diagnostics market is segmented into infectious disease diagnostics, oncology testing, genetic tests and other applications.